Skip to main content

Table 1 Demographics of transplant cohort

From: The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipients

Variable N = 60
Female (%) 28 (46.7)
Deceased donor (%) 32 (53.3)
Ethnicity (%)  
 -Caucasian 34 (57)
 -East Asian 16 (26.7)
 -South Asian 5 (8.3)
 -Black 2 (3.3)
 -Other 3 (5.0)
Age at conversion 53.9 ± 9.5
Years post-transplant 7.4 ± 3.8
eGFR at conversion (ml/min) 62 ± 36.2
Tac BID dose pre-conversion (mg/day) 3.1 ± 1.0
Tac OD dose 12 months post-conversion (mg/day) 3.8 ± 1.3*
[Tac C0 BID] pre-conversion (ng/ml) 5.2 ± 1.6
[Tac CO OD] post-conversion (ng/ml) 5.1 ± 1.5
  1. BID twice daily, OD once daily, Tac tacrolimus
  2. *p = 0.007 for Tac dose BID versus OD